Melanoma Clinical Trials in Paris
5 recruitingParis, France
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
MelanomaSolid TumorLymphoma+2 more
Merck Sharp & Dohme LLC370 enrolled17 locationsNCT02332668
Recruiting
Phase 1Phase 2
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
MelanomaHead and Neck Squamous Cell CarcinomaPancreatic Ductal Adenocarcinoma
Ipsen220 enrolled12 locationsNCT06305247
Recruiting
Phase 4
Dabrafenib and/or Trametinib Rollover Study
Melanoma
Novartis Pharmaceuticals100 enrolled28 locationsNCT03340506
Recruiting
Ovarian Reserve and Semen Parameters Evolution During Adjuvant Therapy in Melanoma
Melanoma
Assistance Publique Hopitaux De Marseille80 enrolled12 locationsNCT05429138
Recruiting
Phase 2
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
MelanomaSquamous Cell Carcinoma of Head and Neck
IO Biotech60 enrolled15 locationsNCT05280314